Do We Have the Right Prognostic Index for Diffuse Large B Cell Lymphoma (DLBCL) in the Era of Rituximab?

by WM Tai MBBS(S'pore), MRCP(UK), PL Tang MBBS(Melb), MRCP(Edin), YX Koo MBBS(S'pore), X Hou BSci, KW Tay MBBS(S'pore), ABIM Med Onc(USA), R Quek MBBS(S'pore), MRCP(UK), M Tao MBBS(Lond), MRCP(UK), ST Lim MBBS(S'pore), MRCP(UK)
Published 2011-03-01